List of Tables
Table 1. Global Still’s Disease Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Corticosteroids
Table 3. Key Players of Tocilizumab
Table 4. Key Players of Canakinumab
Table 5. Key Players of Anakinra
Table 6. Key Players of Others
Table 7. Global Still’s Disease Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Still’s Disease Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Still’s Disease Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Still’s Disease Treatment Market Share by Region (2020-2025)
Table 11. Global Still’s Disease Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Still’s Disease Treatment Market Share by Region (2026-2031)
Table 13. Still’s Disease Treatment Market Trends
Table 14. Still’s Disease Treatment Market Drivers
Table 15. Still’s Disease Treatment Market Challenges
Table 16. Still’s Disease Treatment Market Restraints
Table 17. Global Still’s Disease Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Still’s Disease Treatment Market Share by Players (2020-2025)
Table 19. Global Top Still’s Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Still’s Disease Treatment as of 2024)
Table 20. Ranking of Global Top Still’s Disease Treatment Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Still’s Disease Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Still’s Disease Treatment, Headquarters and Area Served
Table 23. Global Key Players of Still’s Disease Treatment, Product and Application
Table 24. Global Key Players of Still’s Disease Treatment, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Still’s Disease Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Still’s Disease Treatment Revenue Market Share by Type (2020-2025)
Table 28. Global Still’s Disease Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Still’s Disease Treatment Revenue Market Share by Type (2026-2031)
Table 30. Global Still’s Disease Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Still’s Disease Treatment Revenue Market Share by Application (2020-2025)
Table 32. Global Still’s Disease Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Still’s Disease Treatment Revenue Market Share by Application (2026-2031)
Table 34. North America Still’s Disease Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Still’s Disease Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Still’s Disease Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Still’s Disease Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Still’s Disease Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Still’s Disease Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Still’s Disease Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Still’s Disease Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Still’s Disease Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Still’s Disease Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Still’s Disease Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Still’s Disease Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Still’s Disease Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Still’s Disease Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Still’s Disease Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 49. AB2 Bio Ltd Company Details
Table 50. AB2 Bio Ltd Business Overview
Table 51. AB2 Bio Ltd Still’s Disease Treatment Product
Table 52. AB2 Bio Ltd Revenue in Still’s Disease Treatment Business (2020-2025) & (US$ Million)
Table 53. AB2 Bio Ltd Recent Development
Table 54. Novartis AG Company Details
Table 55. Novartis AG Business Overview
Table 56. Novartis AG Still’s Disease Treatment Product
Table 57. Novartis AG Revenue in Still’s Disease Treatment Business (2020-2025) & (US$ Million)
Table 58. Novartis AG Recent Development
Table 59. F. Hoffmann-La Roche Ltd Company Details
Table 60. F. Hoffmann-La Roche Ltd Business Overview
Table 61. F. Hoffmann-La Roche Ltd Still’s Disease Treatment Product
Table 62. F. Hoffmann-La Roche Ltd Revenue in Still’s Disease Treatment Business (2020-2025) & (US$ Million)
Table 63. F. Hoffmann-La Roche Ltd Recent Development
Table 64. Swedish Orphan Biovitrum AB Company Details
Table 65. Swedish Orphan Biovitrum AB Business Overview
Table 66. Swedish Orphan Biovitrum AB Still’s Disease Treatment Product
Table 67. Swedish Orphan Biovitrum AB Revenue in Still’s Disease Treatment Business (2020-2025) & (US$ Million)
Table 68. Swedish Orphan Biovitrum AB Recent Development
Table 69. Jubilant Company Details
Table 70. Jubilant Business Overview
Table 71. Jubilant Still’s Disease Treatment Product
Table 72. Jubilant Revenue in Still’s Disease Treatment Business (2020-2025) & (US$ Million)
Table 73. Jubilant Recent Development
Table 74. Hikma Pharmaceuticals PLC Company Details
Table 75. Hikma Pharmaceuticals PLC Business Overview
Table 76. Hikma Pharmaceuticals PLC Still’s Disease Treatment Product
Table 77. Hikma Pharmaceuticals PLC Revenue in Still’s Disease Treatment Business (2020-2025) & (US$ Million)
Table 78. Hikma Pharmaceuticals PLC Recent Development
Table 79. Teva Pharmaceutical Industries Ltd Company Details
Table 80. Teva Pharmaceutical Industries Ltd Business Overview
Table 81. Teva Pharmaceutical Industries Ltd Still’s Disease Treatment Product
Table 82. Teva Pharmaceutical Industries Ltd Revenue in Still’s Disease Treatment Business (2020-2025) & (US$ Million)
Table 83. Teva Pharmaceutical Industries Ltd Recent Development
Table 84. Viatris Company Details
Table 85. Viatris Business Overview
Table 86. Viatris Still’s Disease Treatment Product
Table 87. Viatris Revenue in Still’s Disease Treatment Business (2020-2025) & (US$ Million)
Table 88. Viatris Recent Development
Table 89. Horizon Therapeutics plc Company Details
Table 90. Horizon Therapeutics plc Business Overview
Table 91. Horizon Therapeutics plc Still’s Disease Treatment Product
Table 92. Horizon Therapeutics plc Revenue in Still’s Disease Treatment Business (2020-2025) & (US$ Million)
Table 93. Horizon Therapeutics plc Recent Development
Table 94. Sun Pharmaceutical Industries Ltd Company Details
Table 95. Sun Pharmaceutical Industries Ltd Business Overview
Table 96. Sun Pharmaceutical Industries Ltd Still’s Disease Treatment Product
Table 97. Sun Pharmaceutical Industries Ltd Revenue in Still’s Disease Treatment Business (2020-2025) & (US$ Million)
Table 98. Sun Pharmaceutical Industries Ltd Recent Development
Table 99. Zydus Cadila Company Details
Table 100. Zydus Cadila Business Overview
Table 101. Zydus Cadila Still’s Disease Treatment Product
Table 102. Zydus Cadila Revenue in Still’s Disease Treatment Business (2020-2025) & (US$ Million)
Table 103. Zydus Cadila Recent Development
Table 104. Amneal Pharmaceuticals LLC Company Details
Table 105. Amneal Pharmaceuticals LLC Business Overview
Table 106. Amneal Pharmaceuticals LLC Still’s Disease Treatment Product
Table 107. Amneal Pharmaceuticals LLC Revenue in Still’s Disease Treatment Business (2020-2025) & (US$ Million)
Table 108. Amneal Pharmaceuticals LLC Recent Development
Table 109. Dr Reddy's Laboratories Ltd Company Details
Table 110. Dr Reddy's Laboratories Ltd Business Overview
Table 111. Dr Reddy's Laboratories Ltd Still’s Disease Treatment Product
Table 112. Dr Reddy's Laboratories Ltd Revenue in Still’s Disease Treatment Business (2020-2025) & (US$ Million)
Table 113. Dr Reddy's Laboratories Ltd Recent Development
Table 114. Fresenius Kabi AG Company Details
Table 115. Fresenius Kabi AG Business Overview
Table 116. Fresenius Kabi AG Still’s Disease Treatment Product
Table 117. Fresenius Kabi AG Revenue in Still’s Disease Treatment Business (2020-2025) & (US$ Million)
Table 118. Fresenius Kabi AG Recent Development
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
Table 122. Authors List of This Report
List of Figures
Figure 1. Still’s Disease Treatment Picture
Figure 2. Global Still’s Disease Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Still’s Disease Treatment Market Share by Type: 2024 VS 2031
Figure 4. Corticosteroids Features
Figure 5. Tocilizumab Features
Figure 6. Canakinumab Features
Figure 7. Anakinra Features
Figure 8. Others Features
Figure 9. Global Still’s Disease Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Still’s Disease Treatment Market Share by Application: 2024 VS 2031
Figure 11. Retail Pharmacies Case Studies
Figure 12. Hospital Pharmacies Case Studies
Figure 13. Online Pharmacies Case Studies
Figure 14. Still’s Disease Treatment Report Years Considered
Figure 15. Global Still’s Disease Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Still’s Disease Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Still’s Disease Treatment Market Share by Region: 2024 VS 2031
Figure 18. Global Still’s Disease Treatment Market Share by Players in 2024
Figure 19. Global Top Still’s Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Still’s Disease Treatment as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Still’s Disease Treatment Revenue in 2024
Figure 21. North America Still’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Still’s Disease Treatment Market Share by Country (2020-2031)
Figure 23. United States Still’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Still’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Still’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Still’s Disease Treatment Market Share by Country (2020-2031)
Figure 27. Germany Still’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Still’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Still’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Still’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Still’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Still’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Still’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Still’s Disease Treatment Market Share by Region (2020-2031)
Figure 35. China Still’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Still’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Still’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Still’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Still’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Still’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Still’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Still’s Disease Treatment Market Share by Country (2020-2031)
Figure 43. Mexico Still’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Still’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Still’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Still’s Disease Treatment Market Share by Country (2020-2031)
Figure 47. Turkey Still’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Still’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Still’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. AB2 Bio Ltd Revenue Growth Rate in Still’s Disease Treatment Business (2020-2025)
Figure 51. Novartis AG Revenue Growth Rate in Still’s Disease Treatment Business (2020-2025)
Figure 52. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Still’s Disease Treatment Business (2020-2025)
Figure 53. Swedish Orphan Biovitrum AB Revenue Growth Rate in Still’s Disease Treatment Business (2020-2025)
Figure 54. Jubilant Revenue Growth Rate in Still’s Disease Treatment Business (2020-2025)
Figure 55. Hikma Pharmaceuticals PLC Revenue Growth Rate in Still’s Disease Treatment Business (2020-2025)
Figure 56. Teva Pharmaceutical Industries Ltd Revenue Growth Rate in Still’s Disease Treatment Business (2020-2025)
Figure 57. Viatris Revenue Growth Rate in Still’s Disease Treatment Business (2020-2025)
Figure 58. Horizon Therapeutics plc Revenue Growth Rate in Still’s Disease Treatment Business (2020-2025)
Figure 59. Sun Pharmaceutical Industries Ltd Revenue Growth Rate in Still’s Disease Treatment Business (2020-2025)
Figure 60. Zydus Cadila Revenue Growth Rate in Still’s Disease Treatment Business (2020-2025)
Figure 61. Amneal Pharmaceuticals LLC Revenue Growth Rate in Still’s Disease Treatment Business (2020-2025)
Figure 62. Dr Reddy's Laboratories Ltd Revenue Growth Rate in Still’s Disease Treatment Business (2020-2025)
Figure 63. Fresenius Kabi AG Revenue Growth Rate in Still’s Disease Treatment Business (2020-2025)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
